Quantbot Technologies’s Terns Pharmaceuticals TERN Stock Holding History

Quantbot Technologies’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-47,043	Closed	-$2.48M	–	2241
2026 Q1	$2.48M	Buy	+47,043	New	+$1.93M	0.1%	308
2024 Q4	–	Sell	-120,838	Closed	-$1.01M	–	1823
2024 Q3	$1.01M	Buy	120,838 +117,079	+3,115%	+$963K	0.04%	620
2024 Q2	$25.6K	Buy	+3,759	New	+$22.8K	﹤0.01%	1315
2024 Q1	–	Sell	-4,498	Closed	-$29.2K	–	1939
2023 Q4	$29.2K	Buy	4,498 +2,198	+96%	+$11.6K	﹤0.01%	1400
2023 Q3	$11.6K	Buy	+2,300	New	+$14.6K	﹤0.01%	1396

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Quantbot Technologies's TERN Position: Q2 2026 in Review

Quantbot Technologies sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 47,043 shares — an estimated $2.48M sold.

Quantbot Technologies first reported a position in TERN in Q3 2023 and held it in 5 quarters. The position peaked at $2.48M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Quantbot Technologies reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Quantbot Technologies sold 47,043 Terns Pharmaceuticals shares in Q2 2026, an estimated $2.48M.
Quantbot Technologies first reported a position in Terns Pharmaceuticals in Q3 2023 and held it in 5 quarters.
Quantbot Technologies's Terns Pharmaceuticals position peaked at $2.48M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.